Industry Dynamics

Industry News



U.S. Food and Drug Administration Approves Vemlidy® (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients

November 02, 2022--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 m……



AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline

Oct. 20, 2022, AbbVie (NYSE: ABBV) today announced the acquisition of DJS Antibodies Ltd ("DJS"), Under the terms of the agreement, AbbVie will pay DJS shareholders approximately $255 million in cash at cl……



Biogen Announces FDA’s 3-Month Extension of Review Period for the New Drug Application for Tofersen

Oct. 27, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for tofersen by three months.……



$11.6 billion! Pfizer completed its acquisition of Biohaven, a biopharmaceutical company, on October 3

Pfizer (PFE.US) 's $22.6 billion acquisition of Biohaven (BHVN.US) will be completed on October 3, according to the Securities and Exchange Commission.Pfizer announced plans to acquire Biohaven in May. After the acqu……



Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

September 5, 2022 --AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) declin……



FDA Approves Auvelity FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults

NEW YORK, August 29, 2022 (GLOBE NEWSWIRE) – Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, t……

< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 >

Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1